Abstract
The treatment of advanced colorectal cancer has evolved significantly over recent years. The increasing and justified demand for timely and robust evaluation of emerging therapies has led to the careful evaluation of alternative end points for clinical trials beyond overall survival. This review offers insights into the advantages, limitations, and promise of existing and emerging efficacy end points of interest for advanced colorectal cancer.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 135-139 |
| Number of pages | 5 |
| Journal | Current Colorectal Cancer Reports |
| Volume | 5 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jul 2009 |
ASJC Scopus subject areas
- Hepatology
- Oncology
- Gastroenterology